Item 3 is hereby amended and restated to read as follows: The Shares purchased by Nomis Bay were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business). The aggregate purchase price of the 5,148,731 Shares beneficially owned by Nomis Bay is approximately $14,705,420, including brokerage commissions. In addition, in connection with the prior ADS conversions, Nomis Bay paid $270,000 in fees to the Bank of New York Mellon, as depositary. The Shares purchased by BPY were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business). The aggregate purchase price of the 3,419,407 Shares beneficially owned by BPY is approximately $9,785,746, including brokerage commissions. In addition, in connection with the prior ADS conversions, BPY paid $30,000 in fees to the Bank of New York Mellon, as depositary. The Shares held in the Managed Positions were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business). The aggregate purchase price of the 8,568,138 Shares held in the Managed Positions is approximately $24,491,023, including brokerage commissions. In addition, in connection with the prior ADS conversions, the Managed Positions paid $562,500 in fees to the Bank of New York Mellon, as depositary.

Item 4 is hereby amended to add the following: On July 17, 2026, the Reporting Persons entered into a settlement agreement (the "Settlement agreement") with the Issuer, pursuant to which (i) each of Robert Pons, David Stehlin, Dr. Joshua Rosensweig, and Andrew Sriubas (the "Departing Directors") resigned from the Issuer's board of directors (the "Board") and all positions with the Issuer, (ii) the Issuer appointed each of Pinchos (Paul) Fruchthandler, Moshe Rozenbaum and Eliezer Eli Tarlow to serve as a member of the Board as a Class I, Class II and Class III director, respectively, with an initial term expiring at the Issuer's 2026 annual general meeting of shareholders to fill the vacancies resulting from the resignations of the Departing Directors, and (iii) the Reporting Persons irrevocably withdrew their demand that the Issuer call an extraordinary general meeting of shareholders (the "EGM") to vote on various proposals submitted by such Reporting Persons, enabling the Issuer to cancel the EGM scheduled to be held on July 31, 2026. In addition, pursuant to the Settlement Agreement, the Reporting Persons, the Issuer and the Departing Directors agreed to certain litigation-related provisions, including a release of certain claims and a covenant not to initiate or pursue certain legal proceedings, as well as certain non-disparagement provisions. The foregoing description of the Settlement Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Settlement Agreement, which is attached as Exhibit 99.1 hereto and is incorporated herein by reference. On July 20, 2026, the Issuer and the Reporting Persons issued a joint press release announcing the Settlement Agreement. A copy of the press release is attached as Exhibit 99.2 hereto and is incorporated by reference.

Item 5(a) is hereby amended and restated to read as follows: The percentages used in this Schedule 13D are based upon 210,506,899 Shares outstanding, as of June 23, 2026, as reported in the Issuer's Schedule 14A filed on Form DEFC14A with the Securities and Exchange Commission on June 25, 2026. See rows (11) and (13) of the cover pages to this Schedule 13D for the aggregate number of Shares and percentage of the Shares beneficially owned by each of the Reporting Persons. The filing of this Schedule 13D shall not be deemed an admission that the Reporting Persons are, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, the beneficial owners of any securities of the Issuer that he or it does not directly own. Each of the Reporting Persons specifically disclaims beneficial ownership of the securities reported herein that he or it does not directly own.

Item 5(b) is hereby amended and restated to read as follows: See rows (7) through (10) of the cover pages to this Schedule 13D for the number of Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and the sole or shared power to dispose or to direct the disposition.

Item 5(c) is hereby amended and restated to read as follows: The transactions in the Shares by certain of the Reporting Persons since the filing of Amendment No. 17 to the Schedule 13D are set forth in Exhibit 1 and are incorporated herein by reference.

Item 6 is hereby amended to add the following: On July 17, 2026, Murchinson and the Issuer entered into the Agreement defined and described in Item 4 above and attached as Exhibit 99.1 hereto.

Item 7 is hereby amended to add the following exhibits: 1 - Transactions in the Securities. 99.1 - Settlement Agreement by and among Murchinson Ltd., Nomis Bay Ltd., BPY Limited, EOM Management Ltd., James Keyes, Jason Jagessar, Chaja Carlebach, Clarendon Hugh Masters, Marc J. Bistricer, and Nano Dimension Ltd., David Stehlin, Andrew Sriubas, Joshua Rosensweig, Phillip Borenstein and Robert Pons, dated July 17, 2026. 99.2 - Press Release, dated July 20, 2026.